Table 2 Results of nonparametric linkage analysis of genome-wide scanning with LOD score ≥ 1.5 (if two or more adjacent markers, only the one with the highest score listed).
From: Sibling recurrence risk ratio analysis of the metabolic syndrome and its components over time
Trait | Cross-Sectional Diagnosis Marker (LOD) | Lifetime Diagnosis | ||
|---|---|---|---|---|
Episode ≥ 1 Marker (LOD) | Episode ≥ 2 Marker (LOD) | Episode ≥ 3 Marker (LOD) | ||
Hypertension | - | C1g32 (1.6) | C1g32 (1.6) | C1g32 (1.6) |
C17g2 (2.1) | C9g11 (1.7) | C9g11 (1.7) | ||
C22g1 (1.5) | C22g1 (1.5) | C22g1 (1.5) | ||
Obesity (high BMI) | - | - | C8g10 (1.5) | C8g10 (1.5) |
- | C12g3 (1.5) | - | - | |
- | C19g11 (1.5) | - | - | |
Hyperglycemia | - | C3g26 (1.5) | - | - |
- | C8g10 (1.5) | - | - | |
- | C10g8 (1.5) | - | - | |
Hypertriglyceridemia | - | C6g8 (1.8) | - | - |
C10g12 (1.5) | C10g12 (1.6) | - | - | |
- | C13g9 (1.5) | C13g9 (1.5) | C13g9 (1.5) | |
- | C17g2 (1.9) | - | - | |
C22g7 (1.5) | C22g7 (1.5) | C22g7 (1.5) | - | |
Low HDL cholesterol | C9g7 (2.0) | - | - | |
C10g11 (1.5) | - | C10g12 (1.8) | C10g12 (1.6) | |
- | C12g3 (1.8) | - | - | |
- | - | C13g8 (1.5) | C13g8 (1.5) | |
- | C16g3 (1.9) | - | - | |
- | - | C18g9 (1.8) | - | |
C19g3 (1.8) | C19g3 (2.4) | - | - | |
- | - | C22g7 (1.8) | - | |
Metabolic syndrome | - | C9g12 (1.5) | NAA | NA |
- | C10g2 (1.5) | |||
- | C12g3 (1.5) | |||
- | C19g8 (2.0) | |||
- | C22g7 (2.2) | |||